Etretinate in the management of Harlequin siblings

Indian Journal of Pediatrics

Volumn 65, Issue 2, 1998, Pages 320-323

  Pejaver, Ranjan K ^a,b   Prasad, R S ^a   Garg, A K ^a   Jelly, Ali ^a   Shawkat, Salem ^a  

^a King Salman Armed Force Hospital   (Saudi Arabia)

^b M S RAMAIAH MEDICAL COLLEGE   (India)

Author keywords

Congenital ichthyosis; Etretinate; Harlequin feture

Indexed keywords

ETRETINATE;

ANGIOOSTEOHYPERTROPHY SYNDROME; ARTICLE; CAFFEY DISEASE; CALCIFICATION; CASE REPORT; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; HUMAN; ICHTHYOSIS; KERATINOCYTE; MALE; MUSCLE INJURY; NEWBORN;

EID: 0031838135     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02752311     Document Type: Article

References (20)

1. Waring JI. Early mention of a harlequin fetus in America. Am J Dis Child 1932; 43 : 442.
2. Prasad R, Pejaver RK, Al Dusan S. Management and follow-up of Harlequin siblings. Br J Dermat 1994; 130 : 240-243.
3. Kemmett D, Hunter JA. Retinoids in dermatology. Hospital Update 1988; 3 : 1301-1313.
4. Lawlor F, Peiris S. Harlequin fetus successfully treated with etretinate. Br J Dermat 1985; 112 : 585-590.
5. Ward PS, Jones RD. Successful treatment of a Harlequin fetus. Arch Dis Child 1989; 64 : 1309-1310.
6. Rogers M, Scraf C. Harlequin baby treated with etretinate. Paed Dermat 1989; 6 (3) : 216-221.
7. Elias PM, Williams ML. Retinoid, cancer and the skin. Arch Dermatol 1981; 171 : 160-180.
8. Fritsch PO. Retinoids in psoriasis and disorders of keratinization. J Amer Acad Dermatol 1992; 27 (6) : 8-14.
9. Paraviani U, Busslinger A. Etretinate and isotretinoin : two retinoids with different pharmacokinetic profiles. In : Cunliffe WJ, Miller AJ, eds. Retinoid therapy. Lancaster. MTP Press; 1984; pp 11-23.
10. E. Kauffman et al. Retinoid therpay for severe dermatological disorders. Paed 1992; 90 (1) : 119-120.
11. Page S, Ryan T. Diffuse hyperostosis associated with etretinate. Lancet 1985; ii : 397.
12. Poundville J, Bingham EA, Burrows D. Premature epiphyseal closure - a complication of etretinate therapy in children. J Am Acad Dermatol 1987; 15 : 1259.
13. Hodak E, David M, Gadoth N, Sandbank M. Etretinate induced skeletal muscle damage. Br J Dermatol 1987; 116 : 623-626.
14. Glover MT, Petero AM, Atherton DJ. Surveillance for skeletal toxicity of children treated with etretinate. Br J Dermatol 1987; 116 : 609-614.
15. Naldi L, Rozzoni M, Finazzi G, Pini P et al. Etretinate therapy and thrombocytopenia (letter) Br J Dermatol 1991; 124 (4) : 395.
16. Navascues CA, Luavez A, Riestra S, Rodrigo L. Hepatitis due to etretinate : a case report (letter). Medicina Clinica 1991; 96 (17) : 679.
17. Berth-Jones J, Shuttleworth D, Hutchinson PE. A study of etretinate alopecia. Br J Dermatol 1990; 122 (6) : 751-755.
18. David M, Sandbank M, Lowe NJ. Erythema multiform-like eruptions associated with etretinate therapy. Clin Exp Dermatol 1989; 14 (3) : 230-232.
19. McDonagh AJ, Harrington CI. Pseudoporphyria complicating etretinate therapy. Clin Exp Dermatol 1989; 14 (6) : 437-438.
20. Garioch J. Simpson NB. Etretinate and severe nail plate dystrophies. Clin Exp Dermatol 1989; 14 (3) : 261-262.